Associated Papers
Is subretinal AAV gene replacement still the only viable treatment option for choroideremia?
Han RC et al.
Expert Opinion on Orphan Drugs, 2021
Genetic defects of CHM and visual acuity outcome in 24 choroideremia patients from 16 Japanese families.
Hayashi T et al.
Scientific Reports, 2020
The protein truncation test (PTT) as a method of detection for choroideremia mutations.
Beaufrère L et al.
Experimental Eye Research, 1997
Select a paper to view details